Table 1: Characteristics and preoperative abnormalities of patients with gastric cancer.

Parameter Patients
<50 years
(20)
Patients
≥50 years
(112)

Age (years), mean ± SD 0.000
 Range 27–49 50–87
 Median 4870
Sex: female (%)12 (60.0%)49 (43.7%)0.272
Anemia: hemoglobin < 10 g/dL3 (15.0%)23 (20.5%)0.789
Hypoalbuminemia < 3.5 g/dL 5 (25.0%)50 (44.6%)0.163
Comorbidities
 Cardiac disease0 (0%)17 (15.2%)0.132
 Hypertension 3 (15.0%)38 (34.0%)0.155
 Previous stroke0 (0%)8 (7.1%)0.469
 Chronic obstructive pulmonary disease1 (5.6%)15 (13.4%)0.492
 Diabetes mellitus0 (0%)7 (6.2%)0.544
 Cirrhosis 0 (0%)4 (3.6%)0.881
Number of concomitant disease
 015 (75.0%)54 (48.2%)0.049
 14 (20.0%)34 (30.4%)
 21 (5.0%)17 (15.2%)
 30 (0%)7 (6.2%)
ASA score
 I-II19 (95.0%)75 (67.0%)0.022
 III-IV 1 (5.0%)37 (33.0%)
BMI (body mass index) 0.242
Median 2224
Symptoms
 Epigastric pain 12 (60.0%)75 (67.0%)0.727
 Vomiting 3 (15.0%)9 (8.0%)0.565
 Dysphagia 2 (10.0%)14 (12.5%)0.955
 Fatigue 6 (30.0%)41 (36.6%)0.552
 Loss of appetite 6 (30.0%)28 (25.0%)0.847
 Sarcophobia3 (15.0%)10 (8.9%)0.666
 Upper gastrointestinal bleeding 1 (5.0%)8 (7.2%)0.896
 Weight loss 6 (30.0%)66 (58.9%)0.032
Duration of symptoms (months) mean ± SD
Median 1050.030
History of peptic ulcer 1 (5.0%)3 (2.7%)0.876
Family history of gastric cancer 1 (5.0%)7 (6.2%)0.770
Helicobacter pylori infection 5 (25.0%)6 (5.4%)0.013

SD: standard deviation; ASA: American Society of Anesthesiology; BMI: body mass index; values are bilateral.